Pharmerica (PMC) Tops Q4 EPS by 2c

Pharmerica (NYSE: PMC) reported Q4 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $523.5 million versus the consensus estimate of $491.99 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
• Main Street Capital (MAIN) Reports Prelim Q1 Results
• UnitedHealth Group (UNH) Tops Q1 EPS by 29c, Tops on Revenue; Offers FY24 EPS Guidance